Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor
Vascular endothelial growth factor receptor-2 is a dynamic target for therapeutic intervention in various types of cancers. This study was aimed to explore the anti-angiogenic activity of a novel vascular endothelial growth factor receptor–specific inhibitor named F16 in both in vitro and in vivo ex...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IOS Press
2017-11-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317726841 |